Journal of Molecular Cell Biology · 2011 · 126 citations · 23 references
MedicineMolecular BiologyOncologyCancer GeneticsCellular MetabolismMolecular OncologyAlternative SplicingCancer GenomicsCancer MetabolismExon-intron OrganizationMetabolic ReprogrammingMetabolic Reprogramming In CancerAerobic GlycolysisAlternative Splicing RegulationCis-splicing ElementsExonic Splice EnhancersExonic Splicing EnhancersGlycolysisMutually Exclusive ExonsWarburg Effect
Alternative splicing of the pyruvate kinase M gene (PK-M) can generate the M2 isoform and promote aerobic glycolysis and tumor growth. However, the cancer-specific alternative splicing regulation of PK-M is not completely understood. Here, we demonstrate that PK-M is regulated by reciprocal effects on the mutually exclusive exons 9 and 10, such that exon 9 is repressed and exon 10 is activated in cancer cells. Strikingly, exonic, rather than intronic, cis-elements are key determinants of PK-M splicing isoform ratios. Using a systematic sub-exonic duplication approach, we identify a potent exonic splicing enhancer in exon 10, which differs from its homologous counterpart in exon 9 by only two nucleotides. We identify SRSF3 as one of the cognate factors, and show that this serine/arginine-rich protein activates exon 10 and mediates changes in glucose metabolism. These findings provide mechanistic insights into the complex regulation of alternative splicing of a key regulator of the Warburg effect, and also have implications for other genes with a similar pattern of alternative splicing.
23
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David, Mo Chen, Marcela C. Assanah et al. · Nature · 2009 · 1.2K citations · Full text
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Heather R. Christofk, Matthew G. Vander Heiden, Ning Wu et al. · Nature · 2008 · 1K citations